XVARY Composite Score
19
/ 100
Weak
Combines growth, value, risk, and momentum factors into a single institutional-grade score.
Start here if you're new
What it is
Nortech builds complex electronic parts and assemblies for medical, defense, and industrial customers.
How it gets paid
Last year Nortech Systems made $128M in revenue. Printed circuit board assemblies was the main engine at $38M, or 30% of sales.
What just happened
Revenue hit $88M, but EPS still landed at -$0.41.
At a Glance
C balance sheet — red flag territory — real financial stress
10/100 earnings predictability — expect surprises
17.2% return on capital — nothing to write home about
-$0.47 fy2024 eps est
$128M fy2024 rev est
XVARY composite: 19/100 — weak
What They Do
Nortech builds complex electronic parts and assemblies for medical, defense, and industrial customers.
This is a small company that does annoying, hard-to-switch work. If your product needs cables, circuit boards, testing, and final assembly, moving suppliers can delay shipments and create fresh certification headaches. Nortech spreads that work across 7 facilities and 701 employees, which gives customers one vendor instead of a relay race.
How They Make Money
$128M
annual revenue
Printed circuit board assemblies
$38M
+4.4%
Wire and cable assemblies
$30M
+3.0%
Electromechanical box builds
$24M
+4.4%
Engineering, testing, and prototyping
$18M
+3.0%
Supply chain and post-market services
$18M
+3.0%
The Products That Matter
Cables and wiring assemblies
Complex Interconnect Solutions
part of a $128M revenue base
these assemblies sit inside the core manufacturing operation, and the whole company only kept 14.7% gross margin. that tells you pricing power is thin.
mid-teen margin
Circuit board manufacturing
Printed Circuit Board Assemblies
medical and defense exposure
the boards are more technical than basic assembly work, but the business still ran at a -0.5% operating margin. complexity has not translated into clean profitability yet.
-0.5% operating margin
Design and technical services
Value-Added Engineering
supports a $64M medical segment
this is the part meant to keep Nortech from being just another assembler. the problem is simple: $64M of medical revenue still sits inside a company that needed a credit waiver.
differentiation attempt
Key Numbers
23%
debt load
Long-term debt is 23% of capital. Plain English: about a quarter of the funding stack is borrowed money, which matters more when operating margin is only 1.6%.
1.6%
operating margin
Jargon: operating margin → profit after core business costs → so what: on $128M of sales, Nortech kept only about $2.0M before interest and taxes.
17.2%
return on capital
Jargon: return on capital → profit earned on the money used in the business → so what: the assets can produce decent returns when operations are steady.
$8M
long-term debt
Against a market cap near $26M, $8M of debt is real. Deadpan version: lenders have a claim on almost a third of what the stock market says this company is worth.
Financial Health
C
Strength
- balance sheet grade C — very weak — significant financial distress
- risk rank 5 — safer than 5% of stocks
- price stability 10 / 100
- long-term debt $8M (23% of capital)
C — below average. watch for debt servicing and cash burn.
Total Return vs. Market
source: institutional data · return history unavailable
What Just Happened
missed estimates
Revenue hit $88M, but EPS still landed at -$0.41.
Sales surged 189% vs. prior year, yet gross margin was only 14.7%. More volume helped the top line, but the bottom line still looked like a leak.
$32M
revenue
$0.41
eps
14.7%
gross margin
the number that mattered
14.7% gross margin mattered most because a contract manufacturer with thin margins can add a lot of revenue without creating much profit.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. Plain English, no spam.
Weekly updates
Earnings alerts
Plain English
No spam
What Could Go Wrong
The #1 risk is another lender problem tied to the Feb. 27, 2026 credit waiver. this is not abstract balance-sheet theory. it already happened once.
High
Credit covenant pressure
Nortech defaulted on its credit agreement and entered a waiver and amendment on Feb 27, 2026. That tells you the capital structure is now part of the operating story.
Impact: if lender terms tighten again, even a business with only $8M of long-term debt can lose flexibility fast because margins are already thin.
High
Chronic unprofitability
Trailing 12-month net margin is -2.25%, and the recent operating margin was -0.5%. A manufacturer keeping only 14.7% gross margin does not have much room for cost misses.
Impact: all $128M of revenue is exposed to execution slippage when the profit buffer is this thin.
Med
Medical customer concentration
Medical accounts for $64M, or half the business. That is a stabilizer if demand holds. It becomes a problem fast if a key program slips or a large customer leaves.
Impact: a stumble in the largest segment would hit both revenue and factory utilization at the same time.
Med
Institutional retreat
Institutions own just 3.05% of the stock, and holdings fell 21.47% last quarter. This is not deep sponsorship.
Impact: when ownership is this light, small-cap volatility gets amplified because there are fewer patient holders to catch the tape.
you own a manufacturer that lost money on $128M of sales and already needed a waiver from its lender. that combination does not leave much room for another bad quarter.
Source: institutional data · regulatory filings · risk analysis
Pay Attention To
Credit
Any update to the waiver language
The waiver on Feb 27, 2026 is the live wire. If your next filing still reads like a lender negotiation, the turnaround has not earned much trust.
Margin
Gross margin holding above 14.7%
This is the first number to watch. With operating margin already at -0.5%, even a small gross-margin slip can wipe out the restructuring story.
Earnings
Q4 2025 and FY2025 results
You want two things from the next report: cleaner profitability and plain disclosure on lender terms. If you do not get both, the market will keep pricing stress first.
Customer mix
Medical staying near $64M of the revenue base
Medical is half the business. If that segment weakens while aerospace and industrial stay at $32M each, the diversification story gets a lot less comforting.
Analyst Rankings
earnings predictability
10 / 100
in human-speak, forecasts deserve a discount because the business is thin-margin, loss-making, and now dealing with lender pressure.
price stability
10 / 100
this stock does not trade like a calm industrial. it trades like a small cap where every filing can reset the story.
Source: institutional data
Institutional Activity
institutional ownership data for NSYS is being compiled.
Source: institutional data
Price Targets
3-5 year target range
$10
Current price
Target midpoint · from current
Want the deeper analysis?
The full deep dive: DCF model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
See plans from $5/moThe Deep Dive